NJ

Naman Jain

Active Director Designated Partner DIN 11027801
DIN 11027801 First appointment Mar 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Naman Jain

Data last updated:

Naman Jain is a Designated Partner at Jacnova Pharmaceuticals Llp (since 2025). The company operates in Pharma.

DIN 11027801
Primary Designation Designated Partner
Industry Pharma
First Appointment 29 Mar 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner29 Mar 20252025Active

Board colleagues of Naman Jain

NameDINCompanyDesignation
Ajay Kumar Jain11027798Jacnova Pharmaceuticals LlpDesignated Partner
Manav Jain11027800Jacnova Pharmaceuticals LlpDesignated Partner
Ritam Jain11027799Jacnova Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Jacnova Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Naman Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naman Jain

Naman Jain currently holds 1 directorship: Jacnova Pharmaceuticals Llp (Designated Partner, since 29 Mar 2025).

Naman Jain was first appointed on 29 Mar 2025 as Designated Partner at Jacnova Pharmaceuticals Llp.

The current boards of Naman Jain's companies include Ajay Kumar Jain (Jacnova Pharmaceuticals Llp), Manav Jain (Jacnova Pharmaceuticals Llp), Ritam Jain (Jacnova Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available